[Molecular classification of breast cancer].

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cirugía y Cirujanos

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18492427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microarrays in breast cancer research and clinical practice--the future lies ahead.

  2006cited by this paper
• Molecular classification of breast cancer: limitations and potential.

  2006cited by this paper
• Microarray analysis and tumor classification.

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women.

  2006cited by this paper
• p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer

  2005cited by this paper
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

  2005cited by this paper
• A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females

  2005cited by this paper
• Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.

  2005cited by this paper
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

  2005cited by this paper
• When will more useful predictive factors be ready for use?

  2005cited by this paper
• Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

  2005cited by this paper
• The future of breast cancer: the role of prognostic factors

  2005cited by this paper
• Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

  2005cited by this paper
• Molecular evolution of breast cancer

  2005cited by this paper
• Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

  2005cited by this paper
• Breast cancer control: signs of progress, but more work required.

  2005cited by this paper
• Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

  2005cited by this paper
• Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC)

  2005cited by this paper
• Phenotypic and proteomic alterations of acquired trastuzumab resistance

  2005cited by this paper
• Race and the poor prognosis basal breast tumor (BBT) phenotype in the population-based Carolina Breast Cancer Study (CBCS).

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Expression of luminal and basal cytokeratins in human breast carcinoma

  2004cited by this paper
• PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

  2004cited by this paper
• Molecular profiling of breast cancer: clinical implications

  2004cited by this paper
• Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

  2004cited by this paper
• "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.

  2004cited by this paper
• Short communication Identification of chromosomal changes with comparative genomic hybridization in sporadic breast cancer in Mexican women

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

  2003cited by this paper
• Molecular Classification of Breast Carcinomas Using Tissue Microarrays

  2003cited by this paper
• Gene expression profiles of primary breast tumors maintained in distant metastases

  2003cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

  1995cited by this paper

• Potential and Applications of Mn Complexes in Breast Cancer

  2026cites this paper
• Histopathological correlation with molecular classification of breast carcinoma in a rural population of Pune Maharashtra, India

  2026cites this paper
• Spatiotemporal cell type deconvolution leveraging tissue structure

  2026cites this paper
• Tumor Suppressor p53 and MicroRNAs Interaction in Breast Cancer.

  2026influential citation
• Breast cancer histopathological image classification based on collaborative multi-domain feature learning

  2026cites this paper
• RUBCN as a novel prognostic biomarker and therapeutic target in breast cancer

  2026cites this paper
• Ground-Glass Enhancement on Contrast-Enhanced Mammography: A CT-Inspired Qualitative Descriptor for Breast Lesion Characterization

  2026cites this paper
• The impact of glucocorticoid receptor transactivation on context-dependent cell migration dynamics

  2025cites this paper
• Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives

  2025cites this paper
• A Study on Breast Cancer HER2 Status Prediction Based on Visformer and Stacking Ensemble

  2025cites this paper
• The diagnostic value of a breast cancer diagnosis model based on serum MiRNAs and serum tumor markers

  2025cites this paper
• Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies

  2025cites this paper
• Immunohistochemical expression of epidermal growth factor receptor: prognostic value in HER2 positive breast cancer

  2025cites this paper
• Single‐Cell Transcriptomic Analysis Reveals an Aggressive Basal‐Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma

  2025cites this paper
• Epidemiological and molecular profile of breast cancer: a retrospective study in Casablanca, Morocco

  2025cites this paper
• Single cell sequencing and computational findings reveal anti-estrogen receptor-positive breast cancer roles of formononetin

  2025cites this paper
• Comparison of robotic, conventional, and endoscopic nipple-sparing mastectomy with immediate prosthetic breast reconstruction for breast cancer: A systematic review and meta-analysis

  2025cites this paper
• A Novel Integrated Approach: Plant-Mediated Synthesis, in vitro and in silico Evaluation of Silver Nanoparticles for Breast Cancer and Bacterial Therapies

  2025cites this paper
• Validation of an Artificial Intelligence Model for Breast Cancer Molecular Subtyping Using Hematoxylin and Eosin-Stained Whole-Slide Images in a Population-Based Cohort

  2025cites this paper
• HMGA2 associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective

  2025cites this paper
• Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer

  2025cites this paper
• Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes

  2025cites this paper
• Molecular Subtypes and Biomarker-based Detection of Breast Cancer: Challenges and Future Perspectives

  2025cites this paper
• Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer

  2025cites this paper
• Toward Accurate Deep Learning-Based Prediction of Ki67, ER, PR, and HER2 Status From H&E-Stained Breast Cancer Images

  2025cites this paper
• CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy

  2025cites this paper
• Can we use HER2DX to modulate treatment intensity in HER2 positive early breast cancer?

  2025cites this paper
• Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites

  2025cites this paper
• Immunohistochemical expression of Annexin A2 and Annexin A6 in a random sample group of Iraqi women with triple-negative breast cancer

  2025cites this paper
• Lymphangioinvasion detection using the monoclonal antibody D2–40 (Podoplanin)as a clinical predictor of axillary lymph node metastasis in breast cancer patients

  2025cites this paper
• Bioelectric and Epigenetic Landscapes in Lateralized Breast Tumors Reveal Distinct Tumor Microenvironment Signatures

  2025cites this paper
• Therapeutic evaluation of paclitaxel co-loaded PLGA nanoparticles with imatinib, protamine-imatinib, and gefitinib: comparative in vitro studies in MDA-MB-231 breast cancer cells and in vivo investigations in rats

  2025cites this paper
• Insights into the molecular and genetic role of obesity in breast cancer pathogenesis

  2025cites this paper
• miR-125b expression in breast cancer: Insights into subtypes and demographic factors at Hospital Canselor Tuanku Muhriz (HCTM)

  2025cites this paper
• MVP-CBM:Multi-layer Visual Preference-enhanced Concept Bottleneck Model for Explainable Medical Image Classification

  2025cites this paper
• Survival outcomes of HER2 low patients with metastatic breast cancer: a retrospective analysis

  2025cites this paper
• Correlation between ultrasonic features and expression of immunohistochemical factors in invasive ductal carcinoma of the breast

  2025cites this paper
• MicroRNAs como biomarcadores de diagnóstico, pronóstico y predicción en cáncer de mama

  2025cites this paper
• ASCORBYL PALMITATE ENHANCES ANTI-PROLIFERATIVE EFFECT OF TRASTUZUMAB IN HER2-POSITIVE BREAST CANCER CELLS.

  2025cites this paper
• Quercetin as a multi-targeted therapeutic agent in breast cancer: molecular targets and therapeutic potential

  2025cites this paper
• Contrast-enhanced mammography for tumor size assessment and detection of multifocal and multicentric disease in breast cancer subtypes

  2025cites this paper
• Pattern of Breast cancer: A study from western Nepal

  2025cites this paper
• Mutational analysis and protein expression of PI3K/AKT pathway in four mucinous cystadenocarcinoma of the breast

  2025cites this paper
• The Roles of STAT3 and STAT5 in Breast Cancer

  2025cites this paper
• Immunohistochemical Expression of L1CAM in Breast Carcinoma: A Clinicopathological Study

  2025cites this paper
• Metronomic Chemotherapy Response in MDA-MB-231 Triple-Negative Breast Cancer Cells under Nicotine Exposure

  2025cites this paper
• Microbiota relationship between breast, colorectal, and lung cancer types

  2025cites this paper
• Expresión del factor del Silenciamiento de la Transcripción del Elemento Represor 1 (REST) en Cáncer de mama

  2025cites this paper
• HER2-Positive Breast Cancer: A Literature Review

  2025cites this paper
• Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling

  2025cites this paper
• A machine learning computational framework develops a glutamine metabolism immunity index for improving clinical outcomes in lung adenocarcinoma

  2025cites this paper
• The Role of PAX7 in Breast Cancer Prognosis and Its Mechanistic Involvement in the Wnt/β‐Catenin Pathway

  2025cites this paper
• Current Endocrine Therapy in Hormone-Receptor-Positive Breast Cancer: From Tumor Biology to the Rationale for Therapeutic Tunning

  2025cites this paper
• The Kv10.1 potassium channel, driver of hypoxia-induced EMT and breast cancer cell aggressiveness

  2025cites this paper
• PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells

  2025cites this paper
• Synergistic strength: unleashing exercise and polyphenols against breast cancer

  2025influential citation
• Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function

  2024cites this paper
• Influence of continuous nursing model based on network on the postoperative mental status and quality of life of breast cancer patients

  2024cites this paper
• Molecular Profile in Breast Cancer Treatment

  2024cites this paper
• FNDC1 Facilitates Proliferation, Migration, and Invasion of Breast Cancer Cells Through Modulating Wnt/β-Catenin Pathway

  2024cites this paper
• Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis

  2024cites this paper
• Evaluating Biomarker Dynamics in Breast Cancer Post-Neoadjuvant Chemotherapy: A Retrospective Cross-sectional Study

  2024cites this paper
• The novel selective inhibitors of cyclin-dependent kinase 4/6: in vitro and in silico study

  2024cites this paper
• Epidemiological and Histological Profile of Breast Cancer in the Ghrab Chrarda Bni Hsein Region, Morocco

  2024cites this paper
• Integrating Protein Sequence and Expression Level to Analysis Molecular Characterization of Breast Cancer Subtypes

  2024cites this paper
• Application and new findings of scRNA-seq and ST-seq in prostate cancer

  2024cites this paper
• RARE CASE REPORT: SPINDLE CELL CARCINOMA WITH UNUSUAL METASTASIS TO THE BREAST

  2024cites this paper
• Advancing Breast Cancer Detection with Convolutional Neural Networks: A Comparative Analysis of MIAS and DDSM Datasets

  2024cites this paper
• Crosstalk between SUMOylation and other post-translational modifications in breast cancer

  2024cites this paper
• Histopathological and Hormone receptor changes associated with breast cancer in Missan province

  2024cites this paper
• Overexpression of cytoplasmic poly(A)-binding protein 1 as a biomarker for the prognosis and selection of postoperative regimen in breast cancer

  2024cites this paper
• Investigation of TMEM41A's function in breast cancer prognosis and its connection to immune cell infiltration

  2024cites this paper
• Values of magnetic resonance imaging apparent diffusion coefficient for prognostic evaluation and pathological typing of patients with breast cancer

  2024cites this paper
• Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection

  2024cites this paper
• Efficacy and safety of anlotinib combined with chemotherapy in the treatment of metastatic triple negative breast cancer

  2024cites this paper
• Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials

  2024cites this paper
• Analysis of TLR2 in Primary Endocrine Resistant of Breast Cancer.

  2024cites this paper
• Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway

  2024cites this paper
• Two-Stage Gene Selection Technique For Identifying Significant Prognosis Biomarkers In Breast Cancer

  2024cites this paper
• Navigating the Intricacies of Tumor Heterogeneity: An Insight into Potential Prognostic Breast Cancer Biomarkers

  2024cites this paper
• Generation of guideline-based clinical decision trees in oncology using large language models

  2024cites this paper
• HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?

  2024cites this paper
• Different contractility modes control cell escape from multicellular spheroids and tumor explants

  2024cites this paper
• Posttranslational protein modifications as gatekeepers of cancer immunogenicity

  2024cites this paper
• Survival and inferential analysis in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and subsequent sentinel lymph node biopsy: prospective single-center study

  2024cites this paper
• Recent Studies on Aromatase and EGFR Involved in Breast Cancer and their Inhibitors

  2024cites this paper
• Diet quality indices are associated with breast cancer by molecular subtypes in Mexican women

  2024cites this paper
• Public neoantigens in breast cancer immunotherapy (Review)

  2024cites this paper
• Prognostic value of Maspin protein level in patients with triple negative breast cancer

  2024cites this paper
• Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer

  2024cites this paper
• Impact of immunohistochemical expression of kinesin family member 18A (Kif18A) and β-catenin in infiltrating breast carcinoma of no special type

  2024cites this paper
• Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence

  2024cites this paper
• Upregulation of CENPM promotes breast carcinogenesis by altering immune infiltration

  2024cites this paper
• The impact of breast‐conserving surgery and modified radical mastectomy on postoperative wound complications in patients with early breast cancer

  2024cites this paper
• Whole Genome Expression Analysis Identifies Multiple Targeted Integrative Effects of Polyphenol-Rich Propolis on HER-2-Positive Breast Cancer Cell Line

  2024cites this paper
• A Review on the Impact of Aberrant Methylation in Breast Cancer: Diagnostic, Prognostic, and Therapeutic Approaches

  2024cites this paper
• Exploring the Anti-Carcinogenic Effect of Choline in Limiting the Progression of Breast Cancer in Females

  2024cites this paper
• Development of a novel prognostic signature based on single‐cell combined bulk RNA analysis in breast cancer

  2024cites this paper
• Association between ultrasound BI-RADS signs and molecular typing of invasive breast cancer

  2023cites this paper
• Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro

  2023cites this paper